61.34
Bruker Corp stock is traded at $61.34, with a volume of 2.44M.
It is down -0.49% in the last 24 hours and up +8.78% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$61.64
Open:
$61.7
24h Volume:
2.44M
Relative Volume:
1.02
Market Cap:
$9.34B
Revenue:
$3.46B
Net Income/Loss:
$-9.40M
P/E Ratio:
-255.16
EPS:
-0.2404
Net Cash Flow:
$51.30M
1W Performance:
+2.73%
1M Performance:
+8.78%
6M Performance:
+16.46%
1Y Performance:
+44.50%
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BRKR
Bruker Corp
|
61.34 | 9.16B | 3.46B | -9.40M | 51.30M | -0.2404 |
|
ABT
Abbott Laboratories
|
95.63 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
324.73 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.06 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.60 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
95.18 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker (NASDAQ:BRKR) Sparks Fresh Lab Tech Buzz - Kalkine Media
Bruker (NASDAQ:BRKR) Clears A Key Market Test - Kalkine Media
Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS Insider - GlobeNewswire Inc.
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $70 - Moomoo
JPMorgan Maintains an “Overweight rating” on Bruker Corporation (BRKR) - Insider Monkey
Bruker Corp updates its scientific tools portfolio, shares tracked on NASDAQ - AD HOC NEWS
Bruker Introduces High-Throughput Sample-to-Answer Molecular Diagnostics System - Medical Product Outsourcing
Bruker (BRKR) Stock Trades Up, Here Is Why - Yahoo Finance
A Look at Bruker Corp (BRKR) After 4.2% Gain -- GF Value $62.64 vs Price $60.89 - GuruFocus
Trending Industry Today: Bruker Corp Leads Gains In Room-Temp Superconductors Stocks - Moomoo
BRKR Forecast — Price Target — Prediction for 2027 - TradingView
Bruker Is Maintained at Overweight by Barclays - Moomoo
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $60 - 富途牛牛
Bruker Corp (BRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bruker Corp (BRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bruker Corp (BRKR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bruker Stocklong-term growth drivers in life science tools - AD HOC NEWS
Bruker Corp (BRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bruker Corp (BRKR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fidelity Multi-Strategy Credit Fund's Bruker Corp(BRKRP.PFD) Holding History - GuruFocus
Bruker Gains 50.3% in a Year: What's Driving the Rally? - Yahoo Finance
Bruker-imec Project Advances Semiconductor Metrology Technique | Industry News | Jun 2026 - Photonics Spectra
Bruker Corp (BRKR) Stock Up 4.5% and Still Undervalued -- GF Sco - GuruFocus
Bruker Corp (BRKR) Institutional Confidence - TradingKey
Bruker Corp (BRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bruker Corp (BRKR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bruker Corp (BRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bruker (BRKR) EVP exercises options, sells 2,000 pre-planned shares - Stock Titan
Inszone Insurance Services Acquires Sanford, Bruker & Banks, Inc., Adding Over a Century of Experience to Its Roster - Yahoo Finance
Bruker Corp (BRKR) Stock Up 4.4% and Still Undervalued -- GF Sco - GuruFocus
Broker Technologies (BRKR) files Form 144 to sell 2,000 shares (06/15/2026) - Stock Titan
Brown Advisory Inc. Has $113.44 Million Position in Bruker Corporation $BRKR - MarketBeat
Bruker Q2 2025 Earnings Preview - MSN
Bruker Corporation (NASDAQ: BRKR) files S-3 shelf for equity, debt and resale offerings - Stock Titan
Bruker Corp (BRKR) Stock Down 4.0% -- Now Undervalued? GF Score: 85/100 - GuruFocus
What Bruker (BRKR)'s Expanded Diagnostics and Energy-Research Tools Portfolio Means For Shareholders - Yahoo Finance
BRKR News | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker advances 4D proteomics, functional proteoform analysis and hybrid metabolomics at ASMS 2026 - Select Science
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $65 - 富途牛牛
Is Bruker Corporation (BRKR) A Good Stock To Buy Now? - Yahoo Finance
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam - Yahoo Finance
BRKR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Legal & General Group Plc Sells 43,599 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Bruker (BRKR) Up 37.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Bruker (BRKR) Showcases Innovations in Microbiology at ASM Micro - GuruFocus
Bruker (BRKR) Advances Microbial Diagnostics at ASM Microbe 2026 - GuruFocus
Bruker showcases expanded microbiology diagnostics portfolio By Investing.com - Investing.com Canada
Bruker showcases expanded microbiology diagnostics portfolio - Investing.com
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 - Mid Florida Newspapers
Bruker Corporation $BRKR Shares Bought by BNP Paribas Financial Markets - MarketBeat
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bruker Corp Stock (BRKR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jun 15 '26 |
Sale |
54.76 |
2,000 |
109,520 |
128,443 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):